Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcus Biosciences (RCUS) Interest Expenses (2023 - 2025)

Arcus Biosciences (RCUS) has 2 years of Interest Expenses data on record, last reported at $2.0 million in Q4 2025.

  • For Q4 2025, Interest Expenses changed N/A year-over-year to $2.0 million; the TTM value through Dec 2025 reached $3.0 million, changed N/A, while the annual FY2025 figure was $8.0 million, 100.0% up from the prior year.
  • Interest Expenses reached $2.0 million in Q4 2025 per RCUS's latest filing, up from $1.0 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $2.0 million in Q4 2025 and bottomed at $1.0 million in Q1 2024.